14 years of revenue, profit, cash flow and balance-sheet history through FY2025,
from SEC filings — with a computed, factual read of the trend.
Updated Overview →
Growth & profitability
Revenue has declined 10.0% per year over the past 5 years.
Net income has grown faster than revenue (31.7% vs -10.0% per year).
Free cash flow has grown 115.9% per year over the past 5 years.
Financial health
Total debt ($894M) exceeds cash ($198M); net debt is $696M.
Total debt has grown faster than revenue (10.4% vs -10.0% per year).
Shareholder returns
Dividends have been paid for 12 consecutive years, consuming 80.9% of earnings.
The dividend has grown 22.7% per year over the past 5 years.
Revenue & net income
RevenueNet income
Margins (gross / operating / net)
GrossOperatingNet
Return on equity & assets (ROE / ROA)
ROEROA
Free cash flow (CFO − capex)
Free cash flow
Cash vs total debt
CashTotal debt
Cash flow: operating / investing / financing
OperatingInvestingFinancing
Key annual figures
FY
Revenue
Net income
Gross M
Op M
ROE
ROA
FCF
Total debt
Cash
2025
$1M
$321M
0.0%
0.0%
7.9%
6.2%
—
$894M
$198M
2024
$0
$125M
—
—
4.3%
3.6%
—
$397M
$214M
2023
$0
$54M
—
—
3.8%
2.6%
—
$596M
$294M
2022
$0
-$8M
—
—
-0.9%
-0.5%
—
$719M
$13M
2021
$0
$72M
—
—
7.9%
4.4%
—
$673M
$20M
2020
$2M
$81M
10.0%
0.0%
8.8%
5.4%
—
$546M
$19M
2019
$3M
$46M
14.5%
0.0%
5.0%
3.1%
$123M
$555M
$20M
2018
$3M
$58M
12.3%
0.0%
7.5%
4.5%
$98M
$490M
$37M
2017
$3M
$26M
15.3%
0.0%
4.4%
2.2%
$88M
$559M
$7M
2016
$3M
$29M
14.2%
0.0%
6.5%
3.2%
$64M
$450M
$8M
2015
—
$10M
—
—
3.8%
1.5%
$40M
$394M
$11M
2014
—
-$8M
—
—
-7.2%
-1.7%
$3M
$351M
$25M
2013
—
-$395000
—
—
-0.2%
-0.1%
$7M
$259M
$895000
2012
—
$110000
—
—
0.1%
—
—
—
$735000
Revenue & net income
RevenueNet income
Margins (gross / operating / net)
GrossOperatingNet
Return on equity & assets (ROE / ROA)
ROEROA
Free cash flow (CFO − capex, quarterly)
Free cash flow
Cash vs total debt
CashTotal debt
Cash flow: operating / investing / financing
OperatingInvestingFinancing
Key quarterly figures
Quarter
Revenue
Net income
Gross M
Op M
ROE
ROA
FCF
Total debt
Cash
Jun '26
$5M
$89M
0.0%
0.0%
2.0%
1.5%
—
$1.2B
$48M
Mar '26
$4M
$80M
0.0%
0.0%
1.9%
1.5%
—
$895M
$223M
Dec '25
—
$111M
—
—
2.8%
2.2%
—
$894M
$198M
Sep '25
—
$75M
—
—
1.9%
1.5%
—
$894M
$712M
Jun '25
$0
$69M
—
—
2.1%
1.5%
—
$1.2B
$306M
Mar '25
$0
$66M
—
—
2.2%
1.7%
—
$822M
$27M
Dec '24
—
$52M
—
—
1.8%
1.5%
—
$397M
$214M
Sep '24
—
$33M
—
—
1.4%
1.1%
—
$397M
$377M
Jun '24
—
$11M
—
—
0.6%
0.4%
—
$671M
$495M
Mar '24
—
$29M
—
—
1.7%
1.2%
—
$596M
$451M
Dec '23
—
$26M
—
—
1.9%
1.3%
—
$596M
$294M
Sep '23
—
$9M
—
—
0.8%
0.5%
—
$595M
$3M
Jun '23
—
-$484000
—
—
-0.1%
-0.0%
—
$875M
$1M
Mar '23
—
$19M
—
—
2.3%
1.2%
—
$730M
$28M
Dec '22
—
$14M
—
—
1.7%
0.9%
—
$719M
$13M
Sep '22
—
$709000
—
—
0.1%
0.0%
—
$774M
$5M
Jun '22
—
$21M
—
—
2.5%
1.2%
—
$799M
$30M
Mar '22
—
-$43M
—
—
-5.1%
-2.7%
—
$699M
$27M
Dec '21
$0
$18M
—
—
2.0%
1.1%
—
$673M
$20M
Sep '21
$0
$12M
—
—
1.3%
0.7%
—
$673M
$18M
Valuation over time
How the market has priced CTRE against its own fundamentals since 2023-03 —
each month-end's share price set against the most recent annual filing, so the multiple moves
as price runs ahead of (or behind) earnings. Split-adjusted.
The price-to-earnings ratio has fallen from 92.0× (Jan '24) to 26.6× (Nov '26).
The price-to-sales ratio has fallen from 6973.1× (Dec '25) to 6969.2× (Nov '26).
The dividend yield has risen from 2.3% (Mar '23) to 3.0% (Nov '26).
Price / earnings (P/E)
P/E
Price / sales (P/S)
P/S
Dividend yield (%)
Dividend yield %
Frequently asked questions
Is CTRE growing its revenue and profit?
Over the past 5 years, Caretrust Reit, Inc.'s revenue has declined 10.0% per year, and net income grown 31.7% per year. These are computed facts, not advice.
How much debt does CTRE have?
As of FY2025, Caretrust Reit, Inc. reported $894M of total debt against $198M of cash.
What is CTRE's profit margin?
In FY2025, gross margin was —, operating margin —, and net margin 26166.4%.
What is CTRE's P/E ratio?
Caretrust Reit, Inc.'s P/E (TTM) is 24.02 as of the 2026-11-02 close — market cap ÷ net income over the trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year, the same figure as on the CTRE stock page. The valuation chart above sets each month-end's price against the latest annual net income instead, so its latest point (about 26.6× as of Nov '26) can differ. These are computed facts, not advice.
Where does this data come from?
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), split-adjusted; price return — dividends not reinvested ·
growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price
against the latest annual filing. Informational only — not investment advice.